Mission, Issues and Goals
ASCIA Immunodeficiency Strategy
for Australia and New Zealand
Improve the health and wellbeing of people with PIDs (primary immunodeficiencies) and minimise the burden on individuals, carers, health services and community.
Issues and Goals
Issue 1. Newborn screening for early diagnosis of severe PID
Goal: Enable early diagnosis of severe combined immunodeficiency (SCID) by newborn screening of the population.
Issue 2. Early diagnosis of other PIDs
Goal: Enable early diagnosis of other PIDs through recognition of early warning signs of PID, appropriate testing and treatment.
Issue 3: Improved access to genomic and immune testing for PID
Goal: Improve access to expert genetic diagnosis by using genomic and immune testing for patients with suspected or recently diagnosed PID, or people with a family history of PID.
Issue 4: Improved access to care for PID
Goal: Ensure equitable access to specialist and multi-disciplinary care for patients with PID, including those living in regional, rural and remote areas.
Issue 5: Improved access to funded and supported PID treatments
Goal: Ensure equitable access to treatments, that are appropriately supported and funded for patients with PID.
Issue 6: Support for PID education and training
Goal: Increase support for PID education and training for patients, carers and health professionals.
Issue 7: Support for PID research and collaborations
Goal: Increase support for multi-disciplinary clinical and laboratory PID research and collaborations.
Issue 8: PID in Indigenous Australian and Maori populations
Goal: Ensure that the priorities of Indigenous Australian and Maori populations are represented in PID diagnosis, care and research.
Content updated November 2020